SOBRsafe Inc.’s (NASDAQ: SOBR) Disruptive Technology Poised to Become the Global Standard for Alcohol Monitoring and Detection
- Alcohol detection and monitoring devices have been in use for years, but the need for faster, discreet technology capable of delivering real-time results became more apparent in the mid-2010s
- In 2015 and 2016, the NIAAA announced challenges seeking alcohol monitoring solutions that provide real-time results; the winning entries were wearable wristbands still at the prototype stage
- Fast-forward to today, and SOBRsafe, a company providing next-generation alcohol detection technology, commercializes its market-validated SOBRcheck(TM) stationary alcohol screening device and the SOBRsure(TM) wearable wristband
- SOBRsafe’s devices feature highly precise sensors that are calibrated for early, low alcohol detection, beginning at about 20 minutes, compared to 45-60 minutes for the leading mandatory ankle monitor
- The company believes its disruptive breakthrough technology could become the global standard for alcohol monitoring and detection, replacing legacy products and testing methods
In 2015 and 2016, the National Institute on Alcohol Abuse and Alcoholism (“NIAAA”), a part of the National Institutes of Health (“NIH”), challenged innovators and entrepreneurs to create a “wearable or otherwise discreet device capable of measuring blood alcohol level in real-time.” The challenge aimed to help solve the disadvantages of the then-preferred technologies for alcohol monitoring.
“Current technology for continuous alcohol monitoring takes a reading every 30 minutes. We are seeking a solution that improves on this interval and most closely approximates real-time monitoring and data collection,” stated the circular from NIAAA explaining the rationale behind the 2015 challenge (https://nnw.fm/v1U9G ).
The winners designed wearable wrist monitors that measure transdermal alcohol concentrations (“TAC”) (https://nnw.fm/3ivrQ ). While these winning entries were prototypes, the competition perhaps inspired the modern alcohol detection and monitoring landscape. Today, there are validated, commercially available transdermal alcohol monitoring devices available on the market, some more capable than others.
One company in particular, SOBRsafe (NASDAQ: SOBR), commercializes its SOBRcheck(TM) stationary screening and SOBRsure(TM) wearable monitoring solutions, which utilize a proprietary transdermal technology that simplifies the alcohol detection process. According to the company, the SOBRsafe transdermal detection technology pairs a NIAAA-awarded transdermal gas sensor with proprietary algorithms to capture alcohol vapor excreted through skin pores alongside other contents of sweat.
The highly precise sensor is engineered and calibrated for early, low alcohol detection, beginning at about 20 minutes, compared to 45-60 minutes for the leading mandatory ankle monitor. The company’s technology, therefore, detects alcohol 2-3x faster than other transdermal alcohol detection solutions (https://nnw.fm/56D77 ).
The SOBRcheck(TM) stationary screening device is designed for facility access control, centralized fleets, and monitoring patients in point-of-care behavioral health facilities. It features the aforementioned gas sensor, which determines the presence or absence of alcohol, and a biometric sensor that scans a fingerprint to authenticate a user’s identity. The device provides administrators with real-time, time-stamped results, delivered via the company’s SOBRsafe software. One adopter of the SOBRcheck(TM) solution, Alternatives Inc., in fact, noted that SOBRcheck(TM) is faster and more sanitary than breathalyzers (https://nnw.fm/9JZa8 ).
The SOBRsure(TM) remote monitoring device, on the other hand, has the same footprint as a wearable wristband. It is designed to discreetly and continuously monitor the presence of alcohol in the system, freeing users from scheduled testing and building trust faster thanks to its continuous monitoring attribute. It also eliminates the embarrassment that accompanies using blow devices or providing urine samples.
Like the SOBRcheck(TM) device, the SOBRsure(TM) features the award-winning gas sensor, as well as GPS tracking capabilities. It relays the results continuously to an app-based reporting interface and sends notifications to parents or administrators whenever it detects alcohol. It also sends alerts containing location data whenever it is removed.
Since the fourth quarter of 2023, SOBRsafe has been marketing its alcohol detection and monitoring solutions to the behavioral health market. “In 2024, and consistent with our strategy, we have now established our technology, with our first revenue-generating customers in behavioral health growing to 35 accounts in the first and second quarters of this year. In addition, we entered the equivalent verticals in Australia and New Zealand and are gaining traction through a channel partner that we’re very, very excited about,” said SOBRsafe CEO Dave Gandini in a recent video update (https://nnw.fm/oQGBP ).
The company is also targeting further international expansion and has invested in a marketing campaign that aims to present its solutions to more than 45,000 behavioral health decision-makers in the U.S. “We believe that our approach will increase demand, drive sales and gain market share for us in the fourth quarter and on into 2025,” Gandini continued.
The company believes its disruptive breakthrough technology could become the global standard for alcohol monitoring and detection, replacing legacy products and testing methods. And with its international expansion and robust marketing campaign underway, coupled with the strong adoption in the core behavioral health vertical since late 2023, the company is a worthy consideration for investors.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
- Alcohol detection and monitoring devices have been in use for years, but the need for faster, discreet technology capable of delivering real-time results became more apparent in the mid-2010s
- In 2015 and 2016, the NIAAA announced challenges seeking alcohol monitoring solutions that provide real-time results; the winning entries were wearable wristbands still at the prototype stage
- Fast-forward to today, and SOBRsafe, a company providing next-generation alcohol detection technology, commercializes its market-validated SOBRcheck(TM) stationary alcohol screening device and the SOBRsure(TM) wearable wristband
- SOBRsafe’s devices feature highly precise sensors that are calibrated for early, low alcohol detection, beginning at about 20 minutes, compared to 45-60 minutes for the leading mandatory ankle monitor
- The company believes its disruptive breakthrough technology could become the global standard for alcohol monitoring and detection, replacing legacy products and testing methods
In 2015 and 2016, the National Institute on Alcohol Abuse and Alcoholism (“NIAAA”), a part of the National Institutes of Health (“NIH”), challenged innovators and entrepreneurs to create a “wearable or otherwise discreet device capable of measuring blood alcohol level in real-time.” The challenge aimed to help solve the disadvantages of the then-preferred technologies for alcohol monitoring.
“Current technology for continuous alcohol monitoring takes a reading every 30 minutes. We are seeking a solution that improves on this interval and most closely approximates real-time monitoring and data collection,” stated the circular from NIAAA explaining the rationale behind the 2015 challenge (https://nnw.fm/v1U9G ).
The winners designed wearable wrist monitors that measure transdermal alcohol concentrations (“TAC”) (https://nnw.fm/3ivrQ ). While these winning entries were prototypes, the competition perhaps inspired the modern alcohol detection and monitoring landscape. Today, there are validated, commercially available transdermal alcohol monitoring devices available on the market, some more capable than others.
One company in particular, SOBRsafe (NASDAQ: SOBR), commercializes its SOBRcheck(TM) stationary screening and SOBRsure(TM) wearable monitoring solutions, which utilize a proprietary transdermal technology that simplifies the alcohol detection process. According to the company, the SOBRsafe transdermal detection technology pairs a NIAAA-awarded transdermal gas sensor with proprietary algorithms to capture alcohol vapor excreted through skin pores alongside other contents of sweat.
The highly precise sensor is engineered and calibrated for early, low alcohol detection, beginning at about 20 minutes, compared to 45-60 minutes for the leading mandatory ankle monitor. The company’s technology, therefore, detects alcohol 2-3x faster than other transdermal alcohol detection solutions (https://nnw.fm/56D77 ).
The SOBRcheck(TM) stationary screening device is designed for facility access control, centralized fleets, and monitoring patients in point-of-care behavioral health facilities. It features the aforementioned gas sensor, which determines the presence or absence of alcohol, and a biometric sensor that scans a fingerprint to authenticate a user’s identity. The device provides administrators with real-time, time-stamped results, delivered via the company’s SOBRsafe software. One adopter of the SOBRcheck(TM) solution, Alternatives Inc., in fact, noted that SOBRcheck(TM) is faster and more sanitary than breathalyzers (https://nnw.fm/9JZa8 ).
The SOBRsure(TM) remote monitoring device, on the other hand, has the same footprint as a wearable wristband. It is designed to discreetly and continuously monitor the presence of alcohol in the system, freeing users from scheduled testing and building trust faster thanks to its continuous monitoring attribute. It also eliminates the embarrassment that accompanies using blow devices or providing urine samples.
Like the SOBRcheck(TM) device, the SOBRsure(TM) features the award-winning gas sensor, as well as GPS tracking capabilities. It relays the results continuously to an app-based reporting interface and sends notifications to parents or administrators whenever it detects alcohol. It also sends alerts containing location data whenever it is removed.
Since the fourth quarter of 2023, SOBRsafe has been marketing its alcohol detection and monitoring solutions to the behavioral health market. “In 2024, and consistent with our strategy, we have now established our technology, with our first revenue-generating customers in behavioral health growing to 35 accounts in the first and second quarters of this year. In addition, we entered the equivalent verticals in Australia and New Zealand and are gaining traction through a channel partner that we’re very, very excited about,” said SOBRsafe CEO Dave Gandini in a recent video update (https://nnw.fm/oQGBP ).
The company is also targeting further international expansion and has invested in a marketing campaign that aims to present its solutions to more than 45,000 behavioral health decision-makers in the U.S. “We believe that our approach will increase demand, drive sales and gain market share for us in the fourth quarter and on into 2025,” Gandini continued.
The company believes its disruptive breakthrough technology could become the global standard for alcohol monitoring and detection, replacing legacy products and testing methods. And with its international expansion and robust marketing campaign underway, coupled with the strong adoption in the core behavioral health vertical since late 2023, the company is a worthy consideration for investors.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
